WHO warns drug resistance is outpacing global targets
WHO officials said on 16 November that progress against antimicrobial resistance is too slow, with a warning of up to 39 million deaths over 25 years, according to Al Jazeera.
Senior officials at the World Health Organization (WHO) said on Monday that the world is not moving fast enough against antimicrobial resistance (AMR), the process by which bacteria and other microbes stop responding to the medicines used to treat them. According to Al Jazeera, which drew on AFP and Reuters reporting, the agency warned that AMR could cause 39 million deaths over the next 25 years and could make routine surgery and childbirth life-threatening.
What WHO officials said
The remarks came at the 6th Annual Global Media Forum on AMR, held virtually. Jean-Pierre Nyemazi, acting director of WHO's AMR department, said resistance is threatening the future of modern medicine, according to Al Jazeera. He also contrasted AMR with COVID-19, noting that drug-resistant infections have been killing people for a long time without the same alarm being raised.
Officials said progress on prevention, diagnosis and appropriate antibiotic use is not keeping pace with global targets. Pravasha Prakash, an AMR technical officer at WHO, said countries are advancing but must speed up to meet 2030 targets.
Verified figures
Several numbers appear both in Al Jazeera's report and in WHO's own AMR fact sheet, dated 16 July 2026:
- About one in six laboratory-confirmed bacterial infections reported worldwide in 2023 was resistant to the antibiotics used to treat it.
- Bacterial AMR was linked to about 4.7 million deaths in 2021. Al Jazeera adds that, per WHO figures, drug-resistant infections directly caused more than one million of those deaths, and that around 4.7 million further deaths were associated with them. The two sources phrase the 4.7 million figure differently, so readers should treat it with care.
National plans and surveillance
According to Al Jazeera, a WHO review of 183 countries this year found that nearly nine in ten had a national AMR action plan, up from about four in ten in 2017. Only 42 countries, fewer than one in five, had a plan that was funded, implemented and monitored.
WHO's fact sheet adds that between 2018 and 2023 resistance rose in more than 40% of monitored pathogen-antibiotic combinations, at an average of 5 to 15% a year. It says resistance is highest in the South-East Asia and Eastern Mediterranean regions, where about one in three reported infections was resistant. The fact sheet also says that in 2022, 'Access' antibiotics made up about 53% of global human use, short of a target of at least 70% by 2030.
Sylvia Bertagnolo, WHO's head of AMR surveillance, stressed the need for testing. Without it, clinicians must treat infections without knowing the cause or which antibiotic will work, according to the Al Jazeera report.
New diagnostic tools and wider response
WHO announced two diagnostic resources, per Al Jazeera: a tool defining which tests should be available at every level of care, from primary care centres to referral hospitals, and a compilation of 73 laboratory procedures covering sample collection through pathogen identification and antibiotic susceptibility testing.
WHO's fact sheet says the World Health Assembly adopted a Global Action Plan on AMR for 2026 to 2036 on 25 May 2026. The plan aims to help reach the 2024 UN General Assembly target of a 10% reduction in bacterial AMR-associated deaths by 2030, using a One Health approach with partner agencies. WHO lists infection prevention, vaccination, better access to water and sanitation, and appropriate antimicrobial use as the main ways to fight AMR.
Analysis
This section is analysis, not reporting. The gap between near-universal planning and the small number of funded, monitored plans suggests that the bottleneck is delivery rather than strategy. The 39 million figure is a long-range projection, so it carries more uncertainty than the measured 2021 and 2023 data.
Sources
Written with automated tools from the sources above and published without editor review. Spotted an error? Tell us · Corrections Policy
Related stories
WHO survey: climate-health plans rise, action still lags
A WHO survey of 146 countries finds over 90% now have climate and health focal points and more than half have plans, but financing, workforce and monitoring gaps are holding back implementation. The report lands as COP31 continues in Türkiye.
Daily GLP-1 pills raise hopes of closing diabetes care gap
Once-daily GLP-1 tablets could be cheaper and easier to store than injections, Al Jazeera reports. WHO backs the drugs conditionally but projects they will reach fewer than 10% of those who could benefit by 2030.
WHO issues new type 1 diabetes guidelines for World Diabetes Day
WHO has published new guidelines on insulin use in adults and its first on type 1 diabetes in children, both aimed at low-resource settings. A separate report asks whether daily pills could widen access to newer drugs.
DR Congo Ebola outbreak passes 11,000 confirmed cases
Government data show 11,042 confirmed Ebola cases and at least 5,387 deaths in DR Congo, in an outbreak of the Bundibugyo strain for which no approved vaccine or treatment exists.
